Biotech News

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

Medpace (MEDP)Medpace2026-06-25 13:46 ESTEarnings

CINCINNATI --(BUSINESS WIRE)--Jun. 16, 2026-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday,

Open original release

Related news

Medpace

Medpace is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States